| __timestamp | Eli Lilly and Company | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4932500000 | 17293000 |
| Thursday, January 1, 2015 | 5037200000 | 26470000 |
| Friday, January 1, 2016 | 5654900000 | 28307000 |
| Sunday, January 1, 2017 | 6070200000 | 30354000 |
| Monday, January 1, 2018 | 4681700000 | 32160000 |
| Tuesday, January 1, 2019 | 4721200000 | 37571000 |
| Wednesday, January 1, 2020 | 5483300000 | 39951000 |
| Friday, January 1, 2021 | 7312800000 | 50159000 |
| Saturday, January 1, 2022 | 6629800000 | 54577000 |
| Sunday, January 1, 2023 | 7082200000 | 61940000 |
| Monday, January 1, 2024 | 8418299999 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding cost dynamics is crucial. Eli Lilly and Company, a stalwart in the pharmaceutical industry, has seen its cost of revenue grow by approximately 44% from 2014 to 2023. This increase reflects the company's strategic investments in research and development, as well as its expansion into new markets. In contrast, Vericel Corporation, a smaller player in the biotech field, has experienced a staggering 258% rise in its cost of revenue over the same period. This growth underscores Vericel's aggressive push to scale its operations and enhance its product offerings. While Eli Lilly's cost of revenue remains significantly higher, Vericel's rapid growth trajectory highlights its potential to disrupt the market. These trends offer a fascinating glimpse into the financial strategies of two distinct companies navigating the complexities of their respective industries.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Johnson & Johnson
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Viatris Inc.
Cost of Revenue Comparison: Eli Lilly and Company vs Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Eli Lilly and Company and Telix Pharmaceuticals Limited's Expenses
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Eli Lilly and Company and Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Eli Lilly and Company and Geron Corporation's Expenses
Cost Insights: Breaking Down Sanofi and Vericel Corporation's Expenses
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue Trends: Vericel Corporation vs Travere Therapeutics, Inc.